Intelligence Platform
Patents
Browse 2,147 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7666411
Methods of treating and preventing colitis involving IL-13 and NK-T cells
granted patentUS 7666846
Cholesterol-containing compounds and their use as immunogens against Borrelia burgdorferi
granted patentUS 7662397
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal
granted patentUS 7662573
Methods for evaluating osteoarthritis risk
granted patentUS 7662592
Bacteriocin inducer peptides
granted patentUS 7662394
Nucleic acids encoding chimeric Flavivirus immunogens comprising the Japanese encephalitis
granted patentUS 7662395
Method of enhancing a targeted immune response against tumors
granted patentUS 7658364
Ocular therapeutic agent delivery devices and methods for making and using such devices
granted patentUS 7655397
Selections of genes and methods of using the same for diagnosis and for targeting the ther
granted patentUS 7655694
Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection
granted patentUS 7641906
Intranasal immunization with detoxified lipooligosaccharide from nontypeable Haemophilus i
granted patentUS 7641909
Avirulent, immunogenic flavivirus chimeras
granted patentUS 7635485
Method of accelerated vaccination against Ebola viruses
granted patentUS 7635486
Recombinant lipidated PsaA protein, methods of preparation and use
granted patentUS 7635688
Development of a preventive vaccine for filovirus infection in primates
granted patentUS 7625736
Methods for preparing immunogenic conjugates
granted patentUS 7622113
Monoclonal antibodies that bind or neutralize dengue virus
granted patentUS 7622123
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
granted patentUS 7622272
Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathol
granted patentUS 7619057
MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
granted patentUS 7612044
Melanoma antigens and their use in diagnostic and therapeutic methods
granted patentUS 7605125
DNA-binding polyamide drug conjugates
granted patentUS 7598077
Compositions and methods for enhancing differential expression
granted patentUS 7598225
Generation of immune response to prostate-specific antigen (PSA)
granted